Bernard Wealth Management’s NanoViricides NNVC Stock Holding History

Bernard Wealth Management’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-500	Closed	-$457	–	351
2026 Q1	$457	Hold	500	–	–	﹤0.01%	330
2025 Q4	$565	Hold	500	–	–	﹤0.01%	320
2025 Q3	$715	Hold	500	–	–	﹤0.01%	300
2025 Q2	$700	Hold	500	–	–	﹤0.01%	285
2025 Q1	$585	Hold	500	–	–	﹤0.01%	364
2024 Q4	$715	Buy	+500	New	+$718	﹤0.01%	294

Other funds holding NNVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bernard Wealth Management's NNVC Position: Q2 2026 in Review

Bernard Wealth Management sold out of NanoViricides (NNVC) in Q2 2026, closing a stake of 500 shares — an estimated $457 sold.

Bernard Wealth Management first reported a position in NNVC in Q4 2024 and held it in 6 quarters. The position peaked at $715 in Q3 2025. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Bernard Wealth Management reported no remaining NanoViricides position as of Q2 2026 after selling out during the quarter.
Bernard Wealth Management sold 500 NanoViricides shares in Q2 2026, an estimated $457.
Bernard Wealth Management first reported a position in NanoViricides in Q4 2024 and held it in 6 quarters.
Bernard Wealth Management's NanoViricides position peaked at $715 in Q3 2025.
48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Bernard Wealth Management's 13F filing for Q2 2026, filed 21 Aug 2026.